补体替代途径决定ANCA相关血管炎易感性与疾病严重程度
在西班牙102例AAV队列(54例活动期、48例缓解期)及100例ANCA相关肾小球肾炎验证队列中,分析CFH/CFHR1-5、CFB、C3、MCP基因变异及血浆补体成分纵向水平。结果显示AP基因变异与疾病易感性(CFB32Q/W)或肾脏损伤严重程度(CFH-H1、CFH1H2、ΔCFHR3/1)相关,诊断时高AP激活与不良结局相关,高基线FHR-1及低FH/FHR-1比值决定严重肾脏AAV。
要点
- AP补体基因变异与AAV易感性(CFB32Q/W)及肾脏损伤严重程度(CFH-H1、CFH1H2、ΔCFHR3/1)相关。
- 诊断时高AP激活与较差疾病结局相关,高基线FHR-1及低FH/FHR-1比值决定严重肾脏AAV。
- FH与FHR-1平衡可能关键,FHR-1被提出作为AAV新型AP特异性治疗靶点。
核心结论
- AP关键遗传与血浆成分决定AAV易感性、预后及严重程度,FH与FHR-1平衡可能关键,FHR-1被提出作为新型AP特异性治疗靶点。
研究设计与样本
- 西班牙AAV队列102例,含活动期54例与未接受免疫抑制剂或透析的缓解期48例;验证队列为100例ANCA相关肾小球肾炎患者。
- 分析CFH/CFHR1-5、CFB、C3和MCP常见基因变异,并纵向测定血浆C3、C4、FH、FHR-1、FHR-2、FHR-5、FB、properdin及sC5b-9水平。
主要发现
- AP补体成分常见基因变异与AAV疾病易感性(CFB32Q/W)或肾脏损伤严重程度(CFH-H1、CFH1H2和ΔCFHR3/1)相关。
- 活动期与缓解期队列血浆补体成分水平显著不同。
- 纵向观察中诊断时高AP激活与较差疾病结局相关,高基线FHR-1水平及较低FH/FHR-1比值决定严重肾脏AAV。
- 上述遗传与血浆发现在验证队列中得到证实。
- 在1例和5例活动期患者中分别鉴定出抗FH和抗C3转化酶自身抗体。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activation of the alternative pathway (AP) of complement is involved in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), although the underlying molecular mechanisms are unclear. To gain insight into the role of the AP, common gene variants in CFH/CFHR1-5, CFB, C3 and MCP, and longitudinal determinations of plasma C3, C4, FH, FHR-1, FHR-2, FHR-5, FB, properdin and sC5b-9 levels were analyzed in a Spanish AAV cohort consisting of 102 patients; 54 with active AAV (active cohort) and 48 in remission not receiving immunosuppressants or dialysis therapy (remission cohort). The validation cohort consisted of 100 patients with ANCA-associated glomerulonephritis. Here, we demonstrated that common genetic variants in complement components of the AP are associated with disease susceptibility (CFB32Q/W) or severity of kidney damage in AAV (CFH-H1, CFH1H2 and ΔCFHR3/1). Plasma levels of complement components were significantly different between active and remission cohorts. In longitudinal observations, a high degree of AP activation at diagnosis was associated with worse disease outcome, while high basal FHR-1 levels and lower FH/FHR-1 ratios determined severe forms of kidney associated AAV. These genetic and plasmatic findings were confirmed in the validation cohort. Additionally, autoantibodies against FH and C3 convertase were identified in one and five active patients, respectively. Thus, our study identified key genetic and plasma components of the AP that determine disease susceptibility, prognosis, and severity in AAV. Our data also suggests that balance between FH and FHR-1 is critical and supports FHR-1 as a novel AP-specific therapeutic target in AAV.
引用
- Lucientes-Continente L, Fernández-Juárez G, Márquez-Tirado B, et al. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Kidney Int. 2023. PMID: 37923132. doi:10.1016/j.kint.2023.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。